Advocacy intelligence hub — real-time data for patient organizations
Tamara C Tamas
National Institute of Allergy and Infectious Diseases (NIAID) — PHASE4
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
National Institute of Allergy and Infectious Diseases (NIAID) — PHASE1
Unity Health Toronto — PHASE3
National Institute of Allergy and Infectious Diseases (NIAID) — PHASE1
ModernaTX, Inc. — PHASE4
PharmaJet, Inc. — PHASE2
Franciscus Gasthuis — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Florian Marks, PhD
University of Cambridge
Jie Li, PhD
Rush University Medical Center
Mikhail Samsonov
R-Pharm
BioNTech Responsible Person
BioNTech SE
Marc H Hemmelder, MD PhD
Maastricht University Medical Center
Alexander Kersten, MD
Uniklinik RWTH Aachen, Klinik für Kardiologie, Angiologie und Internistische Intensivmedizin